Two Berger Montague Attorneys Honored at the American Antitrust Institute’s 2019 Antitrust Enforcement Awards

Berger Montague is pleased to announce that David Sorensen and Nick Urban have won the American Antitrust Institute’s 2019 Outstanding Antitrust Litigation Achievement in Private Practice Award for their work on King Drug Co. of Florence, Inc. v. Cephalon, Inc. (Provigil).

The honorees will be featured at a gala awards dinner on November 12, 2019, following AAI’s Annual Private Antitrust Enforcement Conference.

AAI is an independent, nonprofit organization devoted to promoting competition that protects consumers, businesses, and society. It serves the public through research, education, and advocacy on the benefits of competition and the use of antitrust enforcement as a vital component of national and international competition policy.

Mr. Sorensen is a Managing Shareholder and Co-Chair of the Firm’s Antitrust department. He has played a leading role in numerous antitrust cases representing direct purchasers of prescription drugs. Many of these cases have alleged that pharmaceutical manufacturers have wrongfully kept less expensive generic drugs off the market, in violation of the antitrust laws.

Mr. Urban is a Shareholder in the Antitrust practice group. He focuses on antitrust class actions alleging that pharmaceutical manufacturers wrongfully kept less expensive generic drugs off the market, in violation of the antitrust laws. Mr. Urban has also devoted significant time to antitrust cases brought against the banking industry.

Meet The Team

[ View Bio ]

David F. Sorensen

Executive Shareholder

• [email protected]
• 215-875-5705